ATLAS / Macro Radar / Reporting / DFTX

Definium Therapeutics, Inc. (DFTX) reporting calendar

Definium Therapeutics, Inc. files periodic reports with the SEC as DFTX on Nasdaq. Atlas tracks 18 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 24 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
18

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open DFTX market profile Latest filing on SEC EDGAR ↗ All Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-211989
10-K31 Dec 202526 Feb 202657 days0001193125-26-076742
10-Q30 Sep 20256 Nov 202537 days0001193125-25-269596
10-Q30 Jun 202531 Jul 202531 days0000950170-25-100925
10-Q31 Mar 20258 May 202538 days0000950170-25-066387
10-K31 Dec 20246 Mar 202565 days0000950170-25-034176
10-Q30 Sep 20247 Nov 202438 days0000950170-24-123391
10-Q30 Jun 202413 Aug 202444 days0000950170-24-095753
10-Q31 Mar 20248 May 202438 days0000950170-24-055681
10-K31 Dec 202328 Feb 202459 days0000950170-24-021656
10-Q30 Sep 20232 Nov 202333 days0000950170-23-058248
10-Q30 Jun 20233 Aug 202334 days0000950170-23-038057
10-Q31 Mar 20234 May 202334 days0000950170-23-017907
10-K31 Dec 20229 Mar 202368 days0000950170-23-007053
10-Q30 Sep 202210 Nov 202241 days0000950170-22-024192
10-Q30 Jun 202211 Aug 202242 days0000950170-22-016893
10-Q31 Mar 202216 May 202246 days0000950170-22-009955
10-K31 Dec 202128 Mar 202287 days0000950170-22-004724

Source: SEC EDGAR company submissions for CIK 0001813814. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.